TITLE

Tenofovir works as pre-exposure prophylaxis against HIV, two studies confirm

AUTHOR(S)
Roehr, Bob
PUB. DATE
July 2011
SOURCE
BMJ: British Medical Journal (Overseas & Retired Doctors Edition;7/23/2011, Vol. 343 Issue 7816, p177
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64342116

 

Related Articles

  • Neurological syndrome in an HIV-prevention trial participant randomized to daily tenofovir disoproxil fumarate (300 mg) and emtricitabine (200 mg) in Bondo, Kenya. Owino, Fredrick; Mandala, Justin; Ambia, Julie; Agot, Kawango; Van Damme, Lut // International Medical Case Reports Journal;2013, Vol. 6, p91 

    Side effects of antiretroviral drug use by HIV-positive patients have been extensively studied; however, there are limited data on the side effects of antiretroviral drugs used as an HIV prophylaxis among healthy, HIV-negative individuals. Here we report on an unusual neuropathy in a 24-year-old...

  • THE HIV YEAR IN REVIEW. ANDERSON-MINSHALL, DIANE // Advocate;Dec2014/Jan2015, Issue 1076, p45 

    A timeline is presented of HIV- and AIDS-related events in 2014 including German scientists who reported extracts from the geranium plant Pelargonium sidoides can block HIV from entering human cells, University of Missouri researchers who reported a molecule in soy sauce, EFdA, could be used to...

  • Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir.  // AHFS Consumer Medication Information;Jan2020, p1 

    The combination of elvitegravir, cobicistat, emtricitabine, and tenofovir is used to treat HIV in patients who have not been treated with other medications. Elvitegravir, cobicistat, emtricitabine, and tenofovir is in a class of medications called antivirals. Elvitegravir, emtricitabine, and...

  • Emtricitabine and Tenofovir.  // AHFS Consumer Medication Information;Jan2020, p1 

    The combination of emtricitabine and tenofovir is used along with other medications to treat HIV in patients who are 12 years of age and older. It is also used along with practicing safer sex to help prevent patients, who are at high risk, from getting HIV. Emtricitabine and tenofovir are in a...

  • Effect of Tenofovir on Nucleotidases and Cytokines in HIV-1 Target Cells. Biswas, Nabanita; Rodriguez-Garcia, Marta; Crist, Sarah G.; Shen, Zheng; Bodwell, Jack E.; Fahey, John V.; Wira, Charles R. // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Tenofovir (TFV) has been widely used for pre-exposure prophylaxis of HIV-1 infection with mixed results. While the use of TFV in uninfected individuals for prevention of HIV-1 acquisition is actively being investigated, the possible consequences of TFV exposure for the HIV-target cells and the...

  • Analytic Review of Modeling Studies of ARV Based PrEP Interventions Reveals Strong Influence of Drug-Resistance Assumptions on the Population-Level Effectiveness. Dimitrov, Dobromir; Boily, Marie-Claude; Brown, Elizabeth R.; Hallett, Timothy B. // PLoS ONE;Nov2013, Vol. 8 Issue 11, p1 

    Background: Four clinical trials have shown that oral and topical pre-exposure prophylaxis (PrEP) based on tenofovir may be effective in preventing HIV transmission. The expected reduction in HIV transmission and the projected prevalence of drug resistance due to PrEP use vary significantly...

  • FINDING TRU LOVE? REYNOLDS, DANIEL // Advocate;Dec2014/Jan2015, Issue 1076, p43 

    The article discusses increased use of the pre-exposure prophylaxis (PEP) drug Truvada by HIV-negative gay men to prevent HIV infection. Topics include the efforts by founding editor of "Positive Frontiers" magazine, Alex Garner, to educate the LGBT community on Truvada's use for PrEP, efforts...

  • Sex Hormones Regulate Tenofovir-Diphosphate in Female Reproductive Tract Cells in Culture. Shen, Zheng; Fahey, John V.; Bodwell, Jack E.; Rodriguez-Garcia, Marta; Kashuba, Angela D. M.; Wira, Charles R. // PLoS ONE;Jun2014, Vol. 9 Issue 6, p1 

    The conflicting results of recent pre-exposure prophylaxis (PrEP) trials utilizing tenofovir (TFV) to prevent HIV infection in women led us to evaluate the accumulation of intracellular TFV-diphosphate (TFV-DP) in cells from the female reproductive tract (FRT) and whether sex hormones influence...

  • Chemoprophylaxis With Oral Emtricitabine and Tenofovir Alafenamide Combination Protects Macaques From Rectal Simian/Human Immunodeficiency Virus Infection. Massud, Ivana; Mitchell, James; Babusis, Darius; Deyounks, Frank; Ray, Adrian S.; Rooney, James F.; Heneine, Walid; Miller, Michael D.; García-Lermaad, J. Gerardo; García-Lerma, J Gerardo // Journal of Infectious Diseases;10/1/2016, Vol. 214 Issue 7, p1058 

    Tenofovir alafenamide (TAF) is a novel prodrug of tenofovir that efficiently delivers tenofovir diphosphate to lymphoid cells following oral administration. We investigated whether the combination of TAF and emtricitabine (FTC) could prevent simian/human immunodeficiency virus (SHIV) infection...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics